Aleve

Product NDC: 67751-144
11-digit product format: 677510144
Labeler code: 67751
Product ID: 67751-144_4efb1f81-caf8-0cc8-e063-6394a90a8250
Type: HUMAN OTC DRUG
Nonproprietary name: NAPROXEN SODIUM
Dosage form: TABLET
Route: ORAL
Labeler: Navajo Manufacturing Company Inc.
Application: NDA020204
Marketing category: NDA
Marketing start: 2016-09-17
Substance: NAPROXEN SODIUM
Active strength: 220 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	67751-144	67751-144-05	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 45 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67751-144-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67751-144-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67751-144-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67751-144-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67751-144-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67751-144-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67751-144-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67751-144-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67751-144-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67751-144-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67751-144-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67751-144-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67751-144-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67751-144-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67751-144-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	67751-144-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	67751-144-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	67751-144-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	67751-144-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	67751-144-05	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	67751-144-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	67751-144-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	67751-144-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	67751-144-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	67751-144-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	67751-144-05	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	67751-144-02	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	67751-144-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	67751-144-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	67751-144-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	67751-144-02	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	67751-144-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	67751-144-02	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020204-002	ALEVE	NAPROXEN SODIUM	220MG	TABLET / ORAL		RLD, RS	1994-01-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020204-002	ALEVE	EQ 200MG BASE	TABLET / ORAL	RLD, RS	1994-01-11	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020204-002	ALEVE	EQ 200MG BASE	TABLET / ORAL	RLD, RS	1994-01-11	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N020204-002	ALEVE	220MG	TABLET / ORAL	RLD, RS	1994-01-11	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Aleve
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NAPROXEN SODIUM	220 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9TN87S3A3C	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
849574	Internal RxNorm lookup
849728	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
590f3be2-20df-4643-9114-e7ed4cf9155c	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fef6ad89-235f-4274-ba49-a8e53642473e	Product name	2	20250225
87fed3e6-8fba-48ef-96b0-3a7fb54b96ff	Product name	3	20230306
b5fdaaec-7251-4da6-9cb2-4e9e76939ec8	Product name	1	20200623
e76dbbc1-775d-722c-08ff-ed45e8a80def	Product name	3	20181002
6f4f4521-fd56-1ae6-888b-3b021bd75c7c	Product name	1	20140508
ce67e27d-1d21-5465-4409-b0662dd99d4d	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Indexing SPL table
NDC	Effective	Indexing SPL	Related label
67751-144-01	2023-03-01	f386c649-aed3-0266-e053-dadaa90a7c1a	Aleve
67751-144-02	2023-03-01	f386c649-aed3-0266-e053-dadaa90a7c1a	Aleve
67751-144-03	2023-03-01	f386c649-ac74-0266-e053-dadaa90a7c1a	Aleve
67751-144-04	2023-03-01	f386c649-ac74-0266-e053-dadaa90a7c1a	Aleve
67751-144-05	2023-03-01	f386c649-ac74-0266-e053-dadaa90a7c1a	Aleve
67751-144-01	2023-01-30	f386c649-aed3-0266-e053-dadaa90a7c1a	Aleve
67751-144-02	2023-01-30	f386c649-aed3-0266-e053-dadaa90a7c1a	Aleve
67751-144-03	2023-01-30	f386c649-ac74-0266-e053-dadaa90a7c1a	Aleve
67751-144-04	2023-01-30	f386c649-ac74-0266-e053-dadaa90a7c1a	Aleve
67751-144-05	2023-01-30	f386c649-ac74-0266-e053-dadaa90a7c1a	Aleve

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
67751-144-01	Aleve	1 in 1 POUCH	TABLET	1	5
67751-144-01	Aleve	1 in 1 CARTON	TABLET	1	5
67751-144-02	Aleve	2 in 1 POUCH	TABLET	2	5
67751-144-02	Aleve	1 in 1 CARTON	TABLET	1	5
67751-144-06	Aleve	3 in 1 CARTON	TABLET	3	5
67751-144-06	Aleve	1 in 1 POUCH	TABLET	1	5
67751-144-03	Aleve	1 in 1 CARTON	TABLET	1	3
67751-144-03	Aleve	1 in 1 POUCH	TABLET	1	3
67751-144-04	Aleve	2 in 1 CARTON	TABLET	2	3
67751-144-04	Aleve	1 in 1 POUCH	TABLET	1	3
67751-144-05	Aleve	12 in 1 TRAY	TABLET	12	3
67751-144-05	Aleve	1 in 1 POUCH	TABLET	1	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
67751-144	ALEVE (NAPROXEN SODIUM) TABLET [NAVAJO MANUFACTURING COMPANY INC]	3	Current NDC, Legacy NDC, 6 package rows	20230302_60637aeb-deb6-4747-e053-2a91aa0ad00b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 21 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Aleve Caplets	NAPROXEN SODIUM	Select Consumer Group	3ca84972-f8c9-1881-e063-6294a90a9070	2026-07-03	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve	NAPROXEN SODIUM	Navajo Manufacturing Company Inc.	590f3be2-20df-4643-9114-e7ed4cf9155c	2026-04-08	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204 ndc (product): 67751-144
Aleve Caplets	NAPROXEN SODIUM	Bayer HealthCare LLC.	02941928-128a-2c88-e063-6294a90ac6ba	2026-03-12	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve Headache Pain	NAPROXEN SODIUM	Bayer HealthCare LLC	c69f4926-c5cd-63a0-e053-2a95a90a2ca6	2025-12-04	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve	NAPROXEN SODIUM	Bayer HealthCare LLC.	00ef5b30-71d0-4cb4-84a3-48c67d1cea2a	2025-12-04		Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve Back and Muscle Pain	NAPROXEN SODIUM	Bayer HealthCare LLC.	6376e1b8-52c4-0519-e053-2a91aa0af35f	2025-12-04		Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve Caplets	NAPROXEN SODIUM	Bayer HealthCare LLC.	a3745850-3e32-4884-b315-161bcb9996ed	2025-12-04		Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve Gelcaps	NAPROXEN SODIUM	Bayer HealthCare LLC.	acea54a2-5a92-428e-a778-bb4f9d676782	2025-12-04		Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve Gelcaps	NAPROXEN SODIUM	Bayer HealthCare LLC.	0ad8bbb9-dd5f-4273-b085-ee3e5ed22613	2025-12-04	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve Easy Open Arthritis Cap	NAPROXEN SODIUM	Bayer HealthCare LLC.	3c0ddd25-5a9a-4628-a971-65fe2a9775b5	2025-12-04	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve	NAPROXEN SODIUM	R J General Corporation	46e7b298-9e19-49b6-be71-e4fdcb09a5d4	2025-11-17	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Bayer Aleve	NAPROXEN SODIUM	Unifirst First Aid Corporation	5dd569ca-d03e-410c-af98-4732c823d595	2025-09-09	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve Headache Pain	NAPROXEN SODIUM	Bayer HealthCare LLC.	3ba28e47-1294-bec7-e063-6294a90ac80a	2025-08-05	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve Caplets - Easy Open Arthritis Cap	NAPROXEN SODIUM	Bayer HealthCare LLC.	94f09ef7-0695-4499-83c1-95f1e42baf98	2025-04-10	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve	NAPROXEN SODIUM	Bayer HealthCare LLC.	31bad2d9-c0bb-7f20-e063-6294a90acb17	2025-04-01	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve Back and Muscle Pain	NAPROXEN SODIUM	Bayer HealthCare LLC.	31bae77b-42dd-94eb-e063-6294a90ad570	2025-04-01	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve Headache Pain	NAPROXEN SODIUM	Bayer HealthCare LLC.	31baf777-c805-21ea-e063-6394a90abbd8	2025-04-01	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve	NAPROXEN SODIUM	Lil' Drug Store Products, Inc	abfcf13e-6eba-49e2-8ebf-459348714270	2025-01-06	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Bayer Aleve	NAPROXEN SODIUM	Acme United Corporation	f758201c-28b8-5357-e053-6394a90a1e5d	2023-03-20	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204
Aleve	NAPROXEN SODIUM	Navajo Manufacturing Company Inc	60637aeb-deb6-4747-e053-2a91aa0ad00b	2023-03-01	Warnings	Exact identifier application applno (NDA): 020204 application number: NDA020204 ndc (product): 67751-144

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9TN87S3A3C	NAPROXEN SODIUM	26159-34-2	NAPROXEN SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
849728	Aleve 220 MG Oral Tablet	PSN	590f3be2-20df-4643-9114-e7ed4cf9155c	5
849574	naproxen sodium 220 MG Oral Tablet	PSN	590f3be2-20df-4643-9114-e7ed4cf9155c	5
849728	naproxen sodium 220 MG Oral Tablet [Aleve]	SBD	590f3be2-20df-4643-9114-e7ed4cf9155c	5
849574	naproxen sodium 220 MG Oral Tablet	SCD	590f3be2-20df-4643-9114-e7ed4cf9155c	5
849728	Aleve 220 MG Oral Tablet	SY	590f3be2-20df-4643-9114-e7ed4cf9155c	5
849574	naproxen sodium 220 MG (as naproxen 200 MG) Oral Tablet	SY	590f3be2-20df-4643-9114-e7ed4cf9155c	5
849728	Aleve 220 MG Oral Tablet	PSN	60637aeb-deb6-4747-e053-2a91aa0ad00b	3
849574	naproxen sodium 220 MG Oral Tablet	PSN	60637aeb-deb6-4747-e053-2a91aa0ad00b	3
849728	naproxen sodium 220 MG Oral Tablet [Aleve]	SBD	60637aeb-deb6-4747-e053-2a91aa0ad00b	3
849574	naproxen sodium 220 MG Oral Tablet	SCD	60637aeb-deb6-4747-e053-2a91aa0ad00b	3
849728	Aleve 220 MG Oral Tablet	SY	60637aeb-deb6-4747-e053-2a91aa0ad00b	3
849574	naproxen sodium 220 MG (as naproxen 200 MG) Oral Tablet	SY	60637aeb-deb6-4747-e053-2a91aa0ad00b	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
67751-144-01	67751014401	1 POUCH in 1 CARTON (67751-144-01) / 1 TABLET in 1 POUCH	1 pouch	2016-09-17	0000-00-00	No	No	Current
67751-144-02	67751014402	1 POUCH in 1 CARTON (67751-144-02) / 2 TABLET in 1 POUCH	1 pouch	2016-09-17	0000-00-00	No	No	Current
67751-144-03	67751014403	1 POUCH in 1 CARTON (67751-144-03) / 1 TABLET in 1 POUCH	1 pouch	2017-12-04	0000-00-00	No	No	Current
67751-144-04	67751014404	2 POUCH in 1 CARTON (67751-144-04) / 1 TABLET in 1 POUCH	2 pouch	2017-12-04	0000-00-00	No	No	Current
67751-144-05	67751014405	12 POUCH in 1 TRAY (67751-144-05) > 1 TABLET in 1 POUCH	12 pouch	2017-12-04	0000-00-00	No	No	Current
67751-144-06	67751014406	3 POUCH in 1 CARTON (67751-144-06) / 1 TABLET in 1 POUCH	3 pouch	2025-04-22		No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Aleve	Navajo Manufacturing Company Inc.	2026-04-08	HUMAN OTC DRUG LABEL	5
Aleve	Navajo Manufacturing Company Inc	2023-03-01	HUMAN OTC DRUG LABEL	3